Report Detail
Global Andrographolide Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4675179 |
- 20 February, 2026 |
- Global |
- 95 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Andrographolide Drug market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Significant curative effect: Andrographolide has the effects of clearing heat, detoxifying, antibacterial and anti-inflammatory, and has a good therapeutic effect on upper respiratory tract infections, gastrointestinal infections, urinary system infections and other infectious diseases. Its efficacy is remarkable and has been widely recognized by doctors and patients.
Market demand: With the improvement of people"s living standards and the enhancement of health awareness, the demand for the prevention and treatment of common diseases continues to increase. Andrographolide drug is one of the commonly used antibacterial and anti-inflammatory drugs, and its market demand continues to grow.
This report is a detailed and comprehensive analysis for global Andrographolide Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Andrographolide Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Andrographolide Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Andrographolide Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Andrographolide Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Andrographolide Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Andrographolide Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Tasly Group, Furen Pharmaceutical, Jiuhui Pharmaceutical, Sunflower Pharmaceutical, Nanjing Zhengke Pharmaceutical, Livzon Pharm, HORMOSAN Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Andrographolide Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Capsule
Pill
Tablet
Market segment by Application
Hospital Clinic
Pharmacy
Online Pharmacy
Major players covered
Tasly Group
Furen Pharmaceutical
Jiuhui Pharmaceutical
Sunflower Pharmaceutical
Nanjing Zhengke Pharmaceutical
Livzon Pharm
HORMOSAN Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Andrographolide Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Andrographolide Drug, with price, sales quantity, revenue, and global market share of Andrographolide Drug from 2021 to 2026.
Chapter 3, the Andrographolide Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Andrographolide Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Andrographolide Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Andrographolide Drug.
Chapter 14 and 15, to describe Andrographolide Drug sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Andrographolide Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Capsule
- 1.3.3 Pill
- 1.3.4 Tablet
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Andrographolide Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital Clinic
- 1.4.3 Pharmacy
- 1.4.4 Online Pharmacy
- 1.5 Global Andrographolide Drug Market Size & Forecast
- 1.5.1 Global Andrographolide Drug Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Andrographolide Drug Sales Quantity (2021-2032)
- 1.5.3 Global Andrographolide Drug Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Tasly Group
- 2.1.1 Tasly Group Details
- 2.1.2 Tasly Group Major Business
- 2.1.3 Tasly Group Andrographolide Drug Product and Services
- 2.1.4 Tasly Group Andrographolide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Tasly Group Recent Developments/Updates
- 2.2 Furen Pharmaceutical
- 2.2.1 Furen Pharmaceutical Details
- 2.2.2 Furen Pharmaceutical Major Business
- 2.2.3 Furen Pharmaceutical Andrographolide Drug Product and Services
- 2.2.4 Furen Pharmaceutical Andrographolide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Furen Pharmaceutical Recent Developments/Updates
- 2.3 Jiuhui Pharmaceutical
- 2.3.1 Jiuhui Pharmaceutical Details
- 2.3.2 Jiuhui Pharmaceutical Major Business
- 2.3.3 Jiuhui Pharmaceutical Andrographolide Drug Product and Services
- 2.3.4 Jiuhui Pharmaceutical Andrographolide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Jiuhui Pharmaceutical Recent Developments/Updates
- 2.4 Sunflower Pharmaceutical
- 2.4.1 Sunflower Pharmaceutical Details
- 2.4.2 Sunflower Pharmaceutical Major Business
- 2.4.3 Sunflower Pharmaceutical Andrographolide Drug Product and Services
- 2.4.4 Sunflower Pharmaceutical Andrographolide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Sunflower Pharmaceutical Recent Developments/Updates
- 2.5 Nanjing Zhengke Pharmaceutical
- 2.5.1 Nanjing Zhengke Pharmaceutical Details
- 2.5.2 Nanjing Zhengke Pharmaceutical Major Business
- 2.5.3 Nanjing Zhengke Pharmaceutical Andrographolide Drug Product and Services
- 2.5.4 Nanjing Zhengke Pharmaceutical Andrographolide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Nanjing Zhengke Pharmaceutical Recent Developments/Updates
- 2.6 Livzon Pharm
- 2.6.1 Livzon Pharm Details
- 2.6.2 Livzon Pharm Major Business
- 2.6.3 Livzon Pharm Andrographolide Drug Product and Services
- 2.6.4 Livzon Pharm Andrographolide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Livzon Pharm Recent Developments/Updates
- 2.7 HORMOSAN Pharma
- 2.7.1 HORMOSAN Pharma Details
- 2.7.2 HORMOSAN Pharma Major Business
- 2.7.3 HORMOSAN Pharma Andrographolide Drug Product and Services
- 2.7.4 HORMOSAN Pharma Andrographolide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 HORMOSAN Pharma Recent Developments/Updates
3 Competitive Environment: Andrographolide Drug by Manufacturer
- 3.1 Global Andrographolide Drug Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Andrographolide Drug Revenue by Manufacturer (2021-2026)
- 3.3 Global Andrographolide Drug Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Andrographolide Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Andrographolide Drug Manufacturer Market Share in 2025
- 3.4.3 Top 6 Andrographolide Drug Manufacturer Market Share in 2025
- 3.5 Andrographolide Drug Market: Overall Company Footprint Analysis
- 3.5.1 Andrographolide Drug Market: Region Footprint
- 3.5.2 Andrographolide Drug Market: Company Product Type Footprint
- 3.5.3 Andrographolide Drug Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Andrographolide Drug Market Size by Region
- 4.1.1 Global Andrographolide Drug Sales Quantity by Region (2021-2032)
- 4.1.2 Global Andrographolide Drug Consumption Value by Region (2021-2032)
- 4.1.3 Global Andrographolide Drug Average Price by Region (2021-2032)
- 4.2 North America Andrographolide Drug Consumption Value (2021-2032)
- 4.3 Europe Andrographolide Drug Consumption Value (2021-2032)
- 4.4 Asia-Pacific Andrographolide Drug Consumption Value (2021-2032)
- 4.5 South America Andrographolide Drug Consumption Value (2021-2032)
- 4.6 Middle East & Africa Andrographolide Drug Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Andrographolide Drug Sales Quantity by Type (2021-2032)
- 5.2 Global Andrographolide Drug Consumption Value by Type (2021-2032)
- 5.3 Global Andrographolide Drug Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Andrographolide Drug Sales Quantity by Application (2021-2032)
- 6.2 Global Andrographolide Drug Consumption Value by Application (2021-2032)
- 6.3 Global Andrographolide Drug Average Price by Application (2021-2032)
7 North America
- 7.1 North America Andrographolide Drug Sales Quantity by Type (2021-2032)
- 7.2 North America Andrographolide Drug Sales Quantity by Application (2021-2032)
- 7.3 North America Andrographolide Drug Market Size by Country
- 7.3.1 North America Andrographolide Drug Sales Quantity by Country (2021-2032)
- 7.3.2 North America Andrographolide Drug Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Andrographolide Drug Sales Quantity by Type (2021-2032)
- 8.2 Europe Andrographolide Drug Sales Quantity by Application (2021-2032)
- 8.3 Europe Andrographolide Drug Market Size by Country
- 8.3.1 Europe Andrographolide Drug Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Andrographolide Drug Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Andrographolide Drug Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Andrographolide Drug Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Andrographolide Drug Market Size by Region
- 9.3.1 Asia-Pacific Andrographolide Drug Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Andrographolide Drug Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Andrographolide Drug Sales Quantity by Type (2021-2032)
- 10.2 South America Andrographolide Drug Sales Quantity by Application (2021-2032)
- 10.3 South America Andrographolide Drug Market Size by Country
- 10.3.1 South America Andrographolide Drug Sales Quantity by Country (2021-2032)
- 10.3.2 South America Andrographolide Drug Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Andrographolide Drug Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Andrographolide Drug Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Andrographolide Drug Market Size by Country
- 11.3.1 Middle East & Africa Andrographolide Drug Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Andrographolide Drug Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Andrographolide Drug Market Drivers
- 12.2 Andrographolide Drug Market Restraints
- 12.3 Andrographolide Drug Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Andrographolide Drug and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Andrographolide Drug
- 13.3 Andrographolide Drug Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Andrographolide Drug Typical Distributors
- 14.3 Andrographolide Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Andrographolide Drug. Industry analysis & Market Report on Andrographolide Drug is a syndicated market report, published as Global Andrographolide Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Andrographolide Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
